This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This MET Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y1356 of human MET.
MET
Reactivity: Human, Mouse, Rat
WB, ELISA, IF, ICC
Host: Rabbit
Polyclonal
unconjugated
Application Notes
DB: 1:500
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date
6 months
Xu, Xia, Baker, Zhou, Cha, Voorhees, Fisher: "Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function." in: The Journal of biological chemistry, Vol. 286, Issue 18, pp. 15980-8, (2011) (PubMed).
Target
c-MET (MET)
(Met Proto-Oncogene (MET))
Alternative Name
MET
Background
The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma.